Efficacy of Intra Vitreal Injection of Anti VEGF Bevacizumab in the Treatment of Choroidal Neovascularisation

Aim: To evaluate the efficacy of intravitreal bevacizumab for the treatment of neovascular age related macular degeneration and to assess the improvement in visual acuity, reduction in macular thickness in optical coherence topography. Materials and Methods: A prospective non-randomized clinical study was carried out in 31 eyes in which 31 patients having CNVM were tested for visual acuity and macular thickness were checked before and after intravitreal injection of anti VEGF bevacizumab. Results: There were 2-line improvements in visual acuity by Snellen chart in CNVM patients. 95.65 % of classic CNV and 100% of occult CNV showed reduction in macular thickness. 1 case of Classic CNV showed no improvement till the end of the study because of macular scarring. Conclusion: Intravitreal bevacizumab (1.25 mg) treatment was well tolerated over 4 months with significant safety and efficacy.